Aflibercept (high-dose 8 mg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aflibercept (high-dose 8 mg), covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial [Phase 3]